Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Change in Acquisitions & Divestments (2018 - 2021)

Historic Change in Acquisitions & Divestments for Lemaitre Vascular (LMAT) over the last 5 years, with Q4 2021 value amounting to $3.0 million.

  • Lemaitre Vascular's Change in Acquisitions & Divestments fell 3877.55% to $3.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $3.0 million, marking a year-over-year decrease of 8689.96%. This contributed to the annual value of $84.8 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q4 2021, Lemaitre Vascular's Change in Acquisitions & Divestments is $3.0 million, which was down 3877.55% from $4.9 million recorded in Q4 2020.
  • In the past 5 years, Lemaitre Vascular's Change in Acquisitions & Divestments ranged from a high of $16.6 million in Q4 2019 and a low of $3.0 million during Q1 2020
  • In the last 4 years, Lemaitre Vascular's Change in Acquisitions & Divestments had a median value of $7.0 million in 2019 and averaged $8.1 million.
  • As far as peak fluctuations go, Lemaitre Vascular's Change in Acquisitions & Divestments surged by 12133.33% in 2019, and later crashed by 7048.19% in 2020.
  • Over the past 4 years, Lemaitre Vascular's Change in Acquisitions & Divestments (Quarter) stood at $7.5 million in 2018, then soared by 121.33% to $16.6 million in 2019, then crashed by 70.48% to $4.9 million in 2020, then plummeted by 38.78% to $3.0 million in 2021.
  • Its Change in Acquisitions & Divestments was $3.0 million in Q4 2021, compared to $4.9 million in Q4 2020 and $15.0 million in Q2 2020.